[1] Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

[2] Pathological changes in virus infections of the lower respiratory tract in children

[3] Diagnostic value of nonfluoroscopic percutaneous lung needle aspiration in patients with pneumonia

[4] Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection

[5] Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome

[6] Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice

[7] Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

[8] Severe RSV bronchiolitis in an immunocompromised child

[9] The antiviral activity of SP-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats

[10] Levofloxacin cures experimental pneumonic plague in African green monkeys

[11] Respiratory syncytial virus infection in anti-mu-treated mice

[12] Experimental respiratory syncytial virus pneumonia in cebus monkeys

[13] Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation

[14] Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

[15] Cutting edge: stealth influenza virus replication precedes the initiation of adaptive immunity

[16] Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009

[17] Vitamin C deficiency and susceptibility to endotoxin shock in guinea pigs

[18] Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice